AIA Group Ltd Grows Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

AIA Group Ltd boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 18,533 shares of the medical equipment provider's stock after acquiring an additional 722 shares during the quarter. AIA Group Ltd's holdings in Intuitive Surgical were worth $9,673,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Norges Bank acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $2,401,493,000. Proficio Capital Partners LLC lifted its position in shares of Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock valued at $495,845,000 after acquiring an additional 948,902 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $313,769,000. Wilmington Savings Fund Society FSB boosted its stake in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after acquiring an additional 552,058 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after acquiring an additional 360,591 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Remove Ads

Insider Buying and Selling

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company's stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the firm's stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on ISRG. Robert W. Baird decreased their target price on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 18th. Barclays boosted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Erste Group Bank cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Finally, Piper Sandler reissued an "overweight" rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $611.86.

Intuitive Surgical Trading Down 8.7 %

Shares of NASDAQ ISRG traded down $43.03 on Friday, reaching $451.58. 4,106,917 shares of the company traded hands, compared to its average volume of 1,542,631. The stock has a market capitalization of $160.84 billion, a PE ratio of 70.45, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company has a 50 day moving average of $545.18 and a 200 day moving average of $532.30.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.